Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 13, 2010 07:30 ET | Source: MDRNA, Inc.

MDRNA Reports Potent Anti-Tumor Activity Against Multiple Targets in Liver and Bladder Cancer

BOTHELL, WA--(Marketwire - January 13, 2010) - MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, reported today in vivo data for bladder and liver cancer...
December 24, 2009 08:00 ET | Source: MDRNA, Inc.

MDRNA, Inc. Announces Closing of $1 Million Bridge Loan

BOTHELL, WA--(Marketwire - December 24, 2009) - MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced the closing of a bridge loan pursuant to a...
December 17, 2009 07:59 ET | Source: MDRNA, Inc.

MDRNA, Inc. Announces Patent Allowance Covering Methods for Targeted siRNA Delivery to the Lung

BOTHELL, WA--(Marketwire - December 17, 2009) - MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced that the U.S. Patent and Trademark Office...
December 03, 2009 08:00 ET | Source: MDRNA, Inc.

MDRNA, Inc. Presents Positive Efficacy and Tolerability Data in Non-Human Primates With Proprietary siRNA Compounds

BOTHELL, WA--(Marketwire - December 3, 2009) - MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced presentation of data related to its non-human...
December 01, 2009 08:00 ET | Source: MDRNA, Inc.

MDRNA, Inc. Presents to International Webinar Audience on Innovations in Oncology Drug Discovery, Development & Delivery

BOTHELL, WA--(Marketwire - December 1, 2009) - MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced a webinar presentation related to its RNAi...
November 24, 2009 08:00 ET | Source: MDRNA Inc.

MDRNA Expands RNAi Bladder Cancer Program With the Vancouver Prostate Centre

BOTHELL, WA--(Marketwire - November 24, 2009) - MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced the extension and expansion of its...
November 12, 2009 16:05 ET | Source: MDRNA, Inc.

MDRNA, Inc. Receives NASDAQ Notification

BOTHELL, WA--(Marketwire - November 12, 2009) - MDRNA, Inc. (NASDAQ: MRNA) announced today that on November 6, 2009 it received a letter from The NASDAQ Stock Market, Inc. notifying the Company that,...
November 12, 2009 16:01 ET | Source: MDRNA, Inc.

MDRNA, Inc. Announces Third Quarter 2009 Financial Results

BOTHELL, WA--(Marketwire - November 12, 2009) - MDRNA, Inc. (NASDAQ: MRNA) today reported financial results for the three- and nine-month periods ended September 30, 2009. Net loss for the third...
November 05, 2009 07:59 ET | Source: MDRNA, Inc.

MDRNA, Inc. to Hold Third Quarter 2009 Results Conference Call on Thursday, November 12, 2009 at 4:30 pm Eastern Time

BOTHELL, WA--(Marketwire - November 5, 2009) - MDRNA, Inc. (NASDAQ: MRNA) announced today that it will host a conference call with investors and security analysts on Thursday, November 12, 2009, at...
October 29, 2009 08:02 ET | Source: MDRNA Inc.

MDRNA to Present Data on Tumor Reduction at Cancer Therapy Conference

BOTHELL, WA--(Marketwire - October 29, 2009) - MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced the presentation of data related to its RNAi...